Transplant Service Documentation Requirements
Customize your policy alerts
Sign up for Ambetter Nevada Policy CP.MP.247 alerts
Get alerted when Policy CP.MP.247 changes without checking for updates manually.
Monitor payer policy activity
Defines the clinical documentation and prior authorization requirements for pre-transplant evaluation, transplant listing, and post‑transplant follow-up visits for solid organ and stem cell/bone marrow transplants for members of the health plan.
No material clinical or coverage changes in this revision.
Coverage Criteria
COVERAGE CRITERIA
Requests are medically necessary when ALL of the following required documentation elements are included, as applicable to the request type:
I.A Transplant evaluation requests
- I.A.1: Appropriate prior authorization form
- I.A.2: Complete history and physical within one year (includes HPI, current medications, past medical history, family and social history, complete review of systems, and physical exam including height, weight and BMI)within 1 year
I.B Initial and subsequent listing requests (autologous stem cell, allogeneic stem cell, solid organ)
- I.B.1-3: Appropriate prior authorization form; letter of medical necessity from a transplant service provider with signature; complete history and physical performed by a transplant service provider within 12 months for kidney transplant requests or six months for other transplant requests (includes HPI, list of current medications, past medical history, pertinent family and social history, complete review of systems, and physical exam with height, weight and BMI).H&P within 12 months for kidney; within 6 months for other transplants
- I.B.4: Complete chemistry panel, liver function tests, and complete blood count within 12 months for kidney transplants or six months for other transplants.
- I.B.5: Appropriate organ- and transplant-specific testing and imaging as indicated (examples: liver — INR, MELD/PELD, hepatitis serologies, imaging, biopsy as indicated; kidney — GFR or creatinine clearance if not on dialysis; heart — echocardiogram, right heart catheterization including PVR, NYHA class and peak VO2; lung — PFTs, chest imaging, six-minute walk; pancreas — history of insulin; intestine/multivisceral — documentation of failed TPN; stem cell — most recent bone marrow biopsy as indicated, ECOG or Karnofsky performance status, lumbar puncture if indicated, and donor identification for allogeneic transplants).
- I.B.6-9: Annual dental evaluation/clearance; routine health screening exams per standards of care; appropriate comorbidity testing/clearance; cardiology testing/clearance including echocardiogram and EKG as indicated.
- I.B.10: Serum or urine drug screen within 90 days of request.within 90 days
- I.B.11: Infectious disease screening within one year: CMV and VZV (unless baseline IgG positive), EBV (unless baseline IgG positive), Toxoplasma titer for heart recipients, annual PPD/T-Spot/QuantiFERON for solid organ transplants (unless previously positive), Hepatitis B and C within one year (if baseline positive require viral load within 3 months), RPR within one year, HIV within one year (if baseline positive require CD4 and viral load within 3 months).within 1 year (with specified exceptions)
- I.B.12: Detailed psychosocial evaluation and clearance within 12 months for kidney transplants and six months for other transplants.
II Multiple facilities / additional evaluations
- II.A: Episode of illness resulting in change to transplant eligibility status
- II.B: Member admitted to geographically closer facility and not stable for transfer to previously approved facility due to declining medical status
For corneal transplant, pancreatic islet cell auto‑transplant after pancreatectomy, and parathyroid auto‑transplant after thyroidectomy requests, providers must use the Health Plan‑specific prior authorization form available on the Health Plan website; these procedures are noted separately from the solid organ and stem cell documentation requirements in this policy.
Coverage determinations under this policy are subject to the terms, conditions, exclusions and limitations of the member's coverage documents (for example, evidence of coverage, certificate of coverage, or contract of insurance). State Medicaid provisions take precedence where they conflict with this clinical policy.
Required Documentation Timing & Coding
Provider Actions & Prior Authorization
Prior Authorization Required
Prior authorization is required for transplant evaluation, listing, and post-transplant follow-up visits. Inpatient transplant admissions require a separate authorization. Approved transplant listing authorizations are effective for 12 months; after 12 months a new authorization with updated clinical documentation is required.
- Prior authorization form required for evaluation, listing, and post-transplant follow-up authorizations
- Inpatient transplant admissions require separate authorization
- Listing authorizations valid for 12 months; reauthorization requires updated documentation
Prior Authorization Subject to Plan and Regulatory Rules
Coverage decisions are subject to the member's benefit documents and applicable state/federal rules. This clinical policy is a guide to medical necessity and does not guarantee payment; state Medicaid provisions and Medicare NCDs/LCDs take precedence where applicable.
- Coverage subject to terms, conditions, exclusions and limitations of the member's coverage documents (e.g., EOC, certificate of coverage, policy, contract)
- State Medicaid provisions supersede when in conflict; review Medicare NCDs/LCDs for Medicare members
- Health Plan determines policy effective date and may change or withdraw the policy
Provider Actions
Providers must submit required core documentation for evaluation and transplant listing requests. Requests missing required documentation risk denial. Documentation must demonstrate medical necessity and be consistent with generally accepted standards of medical practice.
- Appropriate prior authorization form is required for all evaluation, listing, and post-transplant follow-up requests
- Letter of medical necessity with provider signature required for listing requests
- Complete history and physical (performed by transplant provider) within 12 months for kidney or within 6 months for other transplants
- Requests lacking required documentation (e.g., missing prior auth form, missing H&P within timeframe, missing required labs) may be denied
Detailed Prelisting Documentation
Detailed prelisting documentation must be provided and tailored to the organ or transplant type. This includes laboratory panels, organ-specific testing, infectious disease screening, psychosocial evaluation, and other clearances.
- Complete chemistry panel, liver function tests, and CBC within 12 months for kidney or within 6 months for other transplants
- Organ-specific testing/examples: INR, MELD/PELD and liver imaging/biopsy (liver); GFR or creatinine clearance if not on dialysis (kidney); echocardiogram, right heart cath and PVR, NYHA class and peak VO2 (heart); pulmonary function tests, imaging, six-minute walk test (lung); history of insulin treatment (pancreas); documentation of failed TPN (intestine/multivisceral)
- Stem cell-specific: recent bone marrow biopsy, ECOG or Karnofsky score, lumbar puncture if indicated, donor identification for allogeneic transplants
- Infectious disease screening within specified timeframes (CMV, VZV, EBV, Toxoplasma for heart, PPD/T-Spot/QuantiFERON, Hep B/C, RPR, HIV) with viral load or CD4 testing when baseline positive
- Annual dental evaluation/clearance, routine health screening, comorbidity and cardiology testing/clearance, and urine/serum drug screen within 90 days
- Detailed psychosocial evaluation and clearance within 12 months for kidney and within 6 months for other transplants
Post-Transplant Follow-Up Visit Documentation
For post-transplant follow-up office visit authorization, submit the prior authorization form plus the discharge summary or history and physical from the transplant inpatient admission. For other unrelated services, check the Health Plan prior authorization tool.
- Prior authorization form plus discharge summary or H&P from the transplant admission required for post-transplant follow-up visits
- Authorization requirements for unrelated services should be verified via the Health Plan's prior authorization tool
Documentation Must Demonstrate Medical Necessity
All documentation submitted must demonstrate medical necessity and be consistent with generally accepted standards of medical practice. The Health Plan developed this policy based on current standards and retains discretion in coverage determinations.
- Documentation should support the clinical rationale for transplant evaluation, listing, or post-transplant care
- Clinical requests are reviewed against evidence-based guidelines, peer-reviewed literature, and accepted medical standards
Evaluation Requirements
Provide required organ‑specific testing and assessments
Include organ‑specific functional and diagnostic testing as required: MELD/INR (and MELD/PELD) and hepatitis serologies for liver; GFR or creatinine clearance for kidney; echocardiogram and right heart catheterization results (including PVR), NYHA class and peak VO2 for heart; pulmonary function tests, chest imaging and six‑minute walk for lung.
- Liver: INR, MELD/PELD score, hepatitis serologies, imaging, biopsy as indicated.
- Kidney: GFR or creatinine clearance if not on dialysis.
- Heart: echo, right heart cath including PVR, NYHA class, peak VO2.
- Lung: PFTs, chest x‑ray/CT, six‑minute walk test.
Follow organ‑specific specialty guidance referenced in policy
Evaluation recommendations in the policy reference specialty guidance and external resources such as UpToDate, KDIGO for kidney, ISHLT for lung, UNOS/OPTN policies, and other cited guidelines; providers should follow applicable specialty guidance when completing evaluations.
- Policy cites KDIGO, ISHLT, UNOS/OPTN, and UpToDate among references for organ‑specific evaluation guidance.
Stem Cell Transplant Candidate Criteria
Stem cell transplant candidate criteria
Stem cell transplant clinical considerations
Contraindications
Active infections and significant comorbidities that would complicate surgery or impair postoperative recovery are important considerations when assessing transplant candidacy; the pre‑transplant evaluation is intended to identify such conditions and to gather clinical data used in medical necessity determinations.
Examples include established infections or recent exposures that increase risk after immunosuppression, advanced cardiorespiratory or end‑organ disease, and other chronic illnesses that substantially raise perioperative morbidity or mortality; specifics are determined by the transplant program evaluation and the plan‑approved medical necessity criteria.
Providers must document relevant evaluations and clearances in submitted materials so the Health Plan can determine whether the member meets medical necessity criteria or whether additional review or separate authorization is required.
Post-Transplant Coverage
Center and Accreditation Requirements
Transplant centers should meet FACT accreditation/participation expectations
The policy references Foundation for the Accreditation of Cellular Therapy (FACT) and implies transplant services should occur at participating/authorized facilities meeting accreditation standards.
- Providers should verify the transplant center's participation/authorization and relevant accreditation (FACT/JACIE) when arranging services.
FACT/JACIE standards cited for cellular therapy
References to FACT/JACIE standards are cited as relevant accreditation standards for hematopoietic cellular therapy product collection, processing and administration (International standards, Version 8.1).
Additional FACT/JACIE accreditation references
Additional references to FACT/JACIE accreditation standards are included in the policy's references and support the expectation that hematopoietic cellular therapy services adhere to these standards.
Definitions & Background
The purpose of the pre‑transplant evaluation is to identify medical, infectious, functional and psychosocial factors that affect the likelihood of a successful transplant and safe postoperative recovery. Evaluations typically include clinical assessment, organ‑specific testing and imaging, laboratory and infectious disease screening, performance‑status assessment, and psychosocial evaluation.
Because infection and malignancy risk increase with lifelong immunosuppression, the pre‑transplant assessment emphasizes screening for prior exposures and active infections, measuring current organ function and comorbid conditions, and documenting fitness for surgery and postoperative care to support decisions about listing and transplantation.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.